CD&R, GS Capital Exit AssuraMed After Nearly 2.5 Years

AssuraMed is providing a relatively quick exit for Clayton, Dubilier & Rice and GS Capital Partners.

Cardinal Health today announced it agreed to buy AssuraMed for $2.07

Share this